BCL2L1 and cancer: EGCG has displayed the induction of apoptosis by enhancing caspase-3, caspase-9, BAD, cyt-c, PTEN, SMAC, and Fas and repressed Bcl-2, Bcl-xL, and c-Myc in cancer cells (198, 199).